Abstract
Analytical expressions were derived to explain the influence of the dissolution/diffusion number (Di) on the time constant and steady-state flux when dispersed drugs are released from a finite matrix. A key novelty of this work is the introduction of a single time-constant that combined the analysis of both dissolution- and diffusion-based systems. Focus is placed on systems with a constant dissolution rate and diffusion coefficient. Solutions, based on the residue theorem, were in agreement with published results describing the transport of estradiol in a polymeric matrix. The experimental cumulative amount of drug released was 0.1 mg/cm2 in 100 hours compared to 0.084 mg/cm2 predicted by the theoretical model. The process time constant, estimated from the first eigenvalue (t0) and a more accurate statistical approach (teff), showed a consistent decrease with increasing Di values. For a dissolution/diffusion number of 0.21, t0 and teff were estimated at 58.44 and 73.02 hrs, respectively. With the presence of a skin layer, teff increased to 575.7 hrs. These results can be used to assess the relative impact of dissolution and diffusion on the time it takes drugs to attain a therapeutic level in the bloodstream.
Keywords: Dissolution/diffusion number, time constant, transdermal
Current Drug Delivery
Title: Dynamics of Dissolution and Diffusion-Controlled Drug Release Systems
Volume: 8 Issue: 2
Author(s): Laurent Simon, Parimala Bolisetty and Maria N. Erazo
Affiliation:
Keywords: Dissolution/diffusion number, time constant, transdermal
Abstract: Analytical expressions were derived to explain the influence of the dissolution/diffusion number (Di) on the time constant and steady-state flux when dispersed drugs are released from a finite matrix. A key novelty of this work is the introduction of a single time-constant that combined the analysis of both dissolution- and diffusion-based systems. Focus is placed on systems with a constant dissolution rate and diffusion coefficient. Solutions, based on the residue theorem, were in agreement with published results describing the transport of estradiol in a polymeric matrix. The experimental cumulative amount of drug released was 0.1 mg/cm2 in 100 hours compared to 0.084 mg/cm2 predicted by the theoretical model. The process time constant, estimated from the first eigenvalue (t0) and a more accurate statistical approach (teff), showed a consistent decrease with increasing Di values. For a dissolution/diffusion number of 0.21, t0 and teff were estimated at 58.44 and 73.02 hrs, respectively. With the presence of a skin layer, teff increased to 575.7 hrs. These results can be used to assess the relative impact of dissolution and diffusion on the time it takes drugs to attain a therapeutic level in the bloodstream.
Export Options
About this article
Cite this article as:
Simon Laurent, Bolisetty Parimala and N. Erazo Maria, Dynamics of Dissolution and Diffusion-Controlled Drug Release Systems, Current Drug Delivery 2011; 8 (2) . https://dx.doi.org/10.2174/156720111794479916
DOI https://dx.doi.org/10.2174/156720111794479916 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers